114 related articles for article (PubMed ID: 6100248)
1. Analysis of the mutation to forskolin-resistance in Y1 adrenocortical tumor cells.
Schimmer BP; Tsao J; Collie G; Wong M; Schulz P
Endocr Res; 1984-1985; 10(3-4):365-86. PubMed ID: 6100248
[TBL] [Abstract][Full Text] [Related]
2. Isolation of forskolin-resistant adrenal cells defective in the adenylate cyclase system.
Schimmer BP; Tsao J
J Biol Chem; 1984 May; 259(9):5376-9. PubMed ID: 6538878
[TBL] [Abstract][Full Text] [Related]
3. Forskolin-resistant Y1 mutants harbor defects associated with the guanyl nucleotide-binding regulatory protein, Gs.
Schimmer BP; Tsao J; Borenstein R; Endrenyi L
J Biol Chem; 1987 Nov; 262(32):15521-6. PubMed ID: 2824464
[TBL] [Abstract][Full Text] [Related]
4. Mutations to forskolin resistance result in loss of adrenocorticotropin receptors and consequent reductions in levels of G protein alpha-subunits.
Qiu R; Tsao J; Kwan WK; Schimmer BP
Mol Endocrinol; 1996 Dec; 10(12):1708-18. PubMed ID: 8961279
[TBL] [Abstract][Full Text] [Related]
5. The roles of cAMP and cAMP-dependent protein kinase in forskolin's actions on Y1 adrenocortical tumor cells.
Schimmer BP; Schulz P
Endocr Res; 1985; 11(3-4):199-209. PubMed ID: 3009170
[TBL] [Abstract][Full Text] [Related]
6. Expression of adenylyl cyclase-4 (AC-4) in Y1 and forskolin-resistant adrenal cells.
Rui X; Al-Hakim A; Tsao J; Albert PR; Schimmer BP
Mol Cell Endocrinol; 2004 Feb; 215(1-2):101-8. PubMed ID: 15026181
[TBL] [Abstract][Full Text] [Related]
7. Forskolin-resistant Y1 adrenal cell mutants are deficient in adenylyl cyclase type 4.
Al-Hakim A; Rui X; Tsao J; Albert PR; Schimmer BP
Mol Cell Endocrinol; 2004 Feb; 214(1-2):155-65. PubMed ID: 15062554
[TBL] [Abstract][Full Text] [Related]
8. Adrenocorticotropin-resistant mutants of the Y1 adrenal cell line fail to express the adrenocorticotropin receptor.
Schimmer BP; Kwan WK; Tsao J; Qiu R
J Cell Physiol; 1995 Apr; 163(1):164-71. PubMed ID: 7896893
[TBL] [Abstract][Full Text] [Related]
9. Responses of Y1 adrenocortical tumor cells to o-nitrophenyl sulfenyl ACTH.
Rae PA; Zinman H; Ramachandran J; Schimmer BP
Mol Cell Endocrinol; 1980 Mar; 17(3):171-9. PubMed ID: 6245980
[TBL] [Abstract][Full Text] [Related]
10. Mutations in cyclic AMP-dependent protein kinase and corticotropin (ACTH)-sensitive adenylate cyclase affect adrenal steroidogenesis.
Rae PA; Gutmann NS; Tsao J; Schimmer BP
Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1896-900. PubMed ID: 221910
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis for the 3',5'-cyclic adenosine monophosphate resistance of Kin mutant Y1 adrenocortical tumor cells.
Olson MF; Krolczyk AJ; Gorman KB; Steinberg RA; Schimmer BP
Mol Endocrinol; 1993 Apr; 7(4):477-87. PubMed ID: 8388994
[TBL] [Abstract][Full Text] [Related]
12. Isolation of mutant adrenocortical tumor cells resistant to cyclic nucleotides.
Schimmer BP; Tsao J; Knapp M
Mol Cell Endocrinol; 1977 Aug; 8(2):135-45. PubMed ID: 200506
[TBL] [Abstract][Full Text] [Related]
13. Decreased levels of guanyl nucleotide-binding regulatory protein alpha-subunits in Y1 adrenocortical tumor cell mutants resistant to forskolin.
Schimmer BP; Tsao J
Mol Endocrinol; 1990 Nov; 4(11):1698-703. PubMed ID: 1704099
[TBL] [Abstract][Full Text] [Related]
14. Forskolin stimulates adenylate cyclase activity, cyclic AMP accumulation, and adrenocorticotropin secretion from mouse anterior pituitary tumor cells.
Heisler S; Reisine T
J Neurochem; 1984 Jun; 42(6):1659-66. PubMed ID: 6144727
[TBL] [Abstract][Full Text] [Related]
15. Adenylate cyclase activity and cyclic AMP production in the outer and inner zones of the adrenal cortex.
Mikami K; Nishikawa T; Strott CA
Biochem Biophys Res Commun; 1985 Jun; 129(3):664-70. PubMed ID: 2990464
[TBL] [Abstract][Full Text] [Related]
16. Recovery of hormonal regulation in protein kinase defective adrenal cells through DNA-mediated gene transfer.
Schimmer BP; Wong M; O'Brien D; Schulz P
J Cell Physiol; 1986 Jan; 126(1):77-83. PubMed ID: 3003121
[TBL] [Abstract][Full Text] [Related]
17. Adenylate cyclase activity in Y1 mouse adrenocortical tumor cells: some properties of the enzyme associated with purified plasma membrane fractions.
Schimmer BP
Can J Biochem Cell Biol; 1983 Jul; 61(7):547-52. PubMed ID: 6313150
[TBL] [Abstract][Full Text] [Related]
18. ACTH-receptor deficient mutants of the Y1 mouse adrenocortical tumor cell line.
Schimmer BP; Kwan WK; Tsao J; Qiu R
Endocr Res; 1995; 21(1-2):139-56. PubMed ID: 7588376
[TBL] [Abstract][Full Text] [Related]
19. Steroidogenesis and extracellular cAMP accumulation in adrenal tumor cell cultures.
Schimmer BP; Zimmerman AE
Mol Cell Endocrinol; 1976 Mar; 4(4):263-70. PubMed ID: 177321
[TBL] [Abstract][Full Text] [Related]
20. Regulation of ornithine decarboxylase activity by corticotropin in adrenocortical tumor cell clones: roles of cyclic AMP and cyclic AMP-dependent protein kinase.
Kudlow JE; Rae PA; Gutmann NS; Schimmer BP; Burrow GN
Proc Natl Acad Sci U S A; 1980 May; 77(5):2767-71. PubMed ID: 6248865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
